Post by Sanofi

Children aged 2 to 11 years with chronic spontaneous urticaria (CSU) now have a new treatment option in the EU – our medicine is now the first targeted treatment option available for certain children with this debilitating skin disease. Read the full announcement: https://lnkd.in/eH53UbrU CC: Regeneron